EXPRESSION OF METALLOPROTEINASE 2 AND 9 AND THEIR INHIBITORS IN RENAL CELL CARCINOMA
Author:
Affiliation:
1. From the Department of Urology and Pathology, Georg-August-University, Gottingen, Germany
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Urology
Reference15 articles.
1. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adeno carcinoma: purification of matrix metalloproteinase 2;Young;Gynecol. Oncol.,1996
2. The role of matrix metalloproteinases and their inhibitors in tumor invasion, metastasis and angiogenesis;Ray;Eur. Respir. J.,1994
3. Analysis of expression of matrix metalloproteinases-2 and -9 in hypopharyngeal squamous cell carcinoma by in situ hybridization;Miyajima;Ann. Otol. Rhinol. Laryngol.,1995
4. Matrix metalloproteinase 9 expression in primary human prostatic adenocarcinoma and benign hyperplasia;Hamdy;Br. J. Cancer,1944
5. Analysis of MT1-MMP and MMP 2 expression in human gastric cancers;Mori;Int. J. Cancer,1997
Cited by 94 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Coiled‐coil domain containing 25 (CCDC25) regulates cell proliferation, migration, and invasion in clear cell renal cell carcinoma by targeting the ILK‐NF‐κB signaling pathway;The FASEB Journal;2024-01-18
2. Decellularized porcine kidney-incorporated hydrogels for cell-laden bioprinting of renal cell carcinoma model;International Journal of Bioprinting;2024-01-12
3. Proteoglycan SPOCK1 as a Poor Prognostic Marker Promotes Malignant Progression of Clear Cell Renal Cell Carcinoma via Triggering the Snail/Slug-MMP-2 Axis-Mediated Epithelial-to-Mesenchymal Transition;Cells;2023-01-17
4. TIMP-2 and IGFBP7 in human kidney biopsies in renal disease;Clinical Kidney Journal;2023-01-16
5. TIMP1 Indicates Poor Prognosis of Renal Cell Carcinoma and Accelerates Tumorigenesis via EMT Signaling Pathway;Frontiers in Genetics;2022-02-25
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3